The Dose Problem: Why Many Patients Quit Too Early Most neurofeedback studies that show significant benefit use 20-40 sessions. Many patients in real-world clinical settings quit after 10-15 sessions, either because they feel some improvement and assume it is “enough,” because the time and financial commitment becomes too much, or because they have not yet…
Ketamine therapy for PTSD uses low dose IV infusions to ease symptoms within hours. In a 2021 trial, 67% of patients responded to six infusions, though a larger veterans trial found no clear benefit.
A full course of TMS therapy costs $6,000 to $15,000 without insurance. Most commercial plans and Medicare cover it for treatment-resistant depression, and appeals, superbills and HSA or FSA funds help you recover more of what you pay.
TMS therapy uses focused magnetic pulses to activate underactive mood circuits in the brain. It mainly helps adults whose depression has not improved on antidepressants, and it is FDA cleared for depression, OCD, smoking cessation and anxious depression.
Neurofeedback for anxiety is EEG biofeedback that rewards calmer brainwave patterns over 20 to 40 sessions. Controlled studies show improvement over a wait list, but sham-controlled evidence is limited, so it is not a first-line anxiety treatment.
Neurofeedback uses real-time brainwave monitoring to train your brain toward healthier patterns. This guide covers how it works, what conditions it treats, the different protocols, costs, and what the research actually supports.
NAD+ may support depression care by restoring mitochondrial energy production, activating sirtuins, and reducing neuroinflammation, though human trial evidence is still limited.
TMS for anxiety is personalized by choosing the brain target, the pulse pattern and a dose set from each patient's motor threshold. It is FDA-cleared for anxiety symptoms that come with major depression, not for generalized anxiety disorder alone.
Deep TMS targets the overactive brain circuits driving OCD using the BrainsWay H7 coil. Learn how it differs from TMS for depression, the symptom provocation approach, response rates, and how it compares to ERP therapy and medication.
Migraine medication splits into acute treatments that stop an attack and preventive treatments that reduce how often attacks occur, from triptans to CGRP-targeted therapies.
At a Glance TMS (Transcranial Magnetic Stimulation) is an FDA-cleared, non-invasive treatment for depression that uses magnetic pulses to stimulate underactive brain circuits. Success rates are impressive: 56-60% of treatment-resistant depression patients respond, and 30-35% achieve full remission. Best candidates: people who have failed 1-2 antidepressants but do not have psychotic features or active seizure…
Hemiplegic migraine is a rare migraine with aura that causes temporary weakness on one side of the body and can look exactly like a stroke. It affects about 0.01 percent of people, runs in families in its FHM form, and is treated with medicines chosen to avoid vasoconstriction.
